KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting (CABG), congenital cardiac defect repair, and hip replacement and may protect against renal injury associated with contrast media.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C109H180N44O30S2 |
M.W/Mr. | 2652 |
Sequence | H-Cys(1)-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH. H-Cys(1)-His-Asp-Ala-Pro-Ile-Gly-Tyr-Asp-OH |
Labeling Target | Epsilon protein kinase C (εPKC) |
Activity | Activator |
Functions | Signal transducer activity |
Target | εPKC |
Organism | Human |
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.